Patents by Inventor Michael TOLOSA

Michael TOLOSA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298469
    Abstract: A bioprocessing system for protein manufacturing from human blood is provided that is compact, integrated and suited for on-demand production and delivery of therapeutic proteins to patients. The patient's own blood can be used as the source of cell extracts for the production of the therapeutic proteins.
    Type: Application
    Filed: June 10, 2022
    Publication date: September 22, 2022
    Inventors: Govind RAO, Yordan KOSTOV, Leah TOLOSA, Kevin TRAN, Monohar Pilli, Michael TOLOSA, Chandrashekar Gurramkonda, Xudong GE, Douglas Frey
  • Publication number: 20210380915
    Abstract: The present invention relates to collapsible and/or foldable fermentation and/or culture vessels fabricated of an adjustable frame including sections of gas permeable material or in the alternative a non-rigid gas permeable polymeric container or bag fabricated of either a gas permeable or non-gas permeable material with the further benefit of more efficient inventory space and disposal space, wherein the gas permeable material or non-gas permeable material comprises an analyte or pH sensing material integrated or impregnated into at least one section of the material.
    Type: Application
    Filed: August 20, 2021
    Publication date: December 9, 2021
    Inventors: GOVIND RAO, YORDAN KOSTOV, MICHAEL TOLOSA, XUDONG GE, VIKASH KUMAR, Vida Rahmatnejad
  • Patent number: 10983056
    Abstract: Embodiments of a cell culture monitoring system are disclosed that may include a device having collimating and filtering components to elicit and detect fluorescence from a substrate located within a reaction vessel. The device may be used to detect changes in pH and dissolved oxygen levels in a liquid contained in the reaction vessel due to growth of living cells. Excitation light beams can be generated and collimated by a beam combiner and directed into the reaction vessel so as to be incident upon the substrate to cause the substrate to fluoresce. Some embodiments include use of expected wavelength offsets and shifted filters/mirrors to improve functionality and reduce space of device components.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: April 20, 2021
    Assignee: Scientific Industries, Inc.
    Inventors: Michael Tolosa, William Chandler, Douglas J. Koebler, Joseph G. Cremonese, Brookman P. March
  • Publication number: 20190250103
    Abstract: Embodiments of a cell culture monitoring system are disclosed that may include a device having collimating and filtering components to elicit and detect fluorescence from a substrate located within a reaction vessel. The device may be used to detect changes in pH and dissolved oxygen levels in a liquid contained in the reaction vessel due to growth of living cells. Excitation light beams can be generated and collimated by a beam combiner and directed into the reaction vessel so as to be incident upon the substrate to cause the substrate to fluoresce. Some embodiments include use of expected wavelength offsets and shifted filters/mirrors to improve functionality and reduce space of device components.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventors: Michael Tolosa, William Chandler, Douglas J. Koebler, Joseph G. Cremonese, Brookman P. March
  • Patent number: 10379047
    Abstract: Embodiments of a cell culture monitoring system are disclosed that may include a device having collimating and filtering components to elicit and detect fluorescence from a substrate located within a reaction vessel. The device may be used to detect changes in pH and dissolved oxygen levels in a liquid contained in the reaction vessel due to growth of living cells. Excitation light beams can be generated and collimated by a beam combiner and directed into the reaction vessel so as to be incident upon the substrate to cause the substrate to fluoresce. Some embodiments include use of expected wavelength offsets and shifted filters/mirrors to improve functionality and reduce space of device components.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: August 13, 2019
    Assignee: Scientific Industries, Inc.
    Inventors: Michael Tolosa, William Chandler, Douglas J. Koebler, Joseph G. Cremonese, Brookman P. March
  • Publication number: 20180149593
    Abstract: Embodiments of a cell culture monitoring system are disclosed that may include a device having collimating and filtering components to elicit and detect fluorescence from a substrate located within a reaction vessel. The device may be used to detect changes in pH and dissolved oxygen levels in a liquid contained in the reaction vessel due to growth of living cells. Excitation light beams can be generated and collimated by a beam combiner and directed into the reaction vessel so as to be incident upon the substrate to cause the substrate to fluoresce. Some embodiments include use of expected wavelength offsets and shifted filters/mirrors to improve functionality and reduce space of device components.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 31, 2018
    Inventors: Yordan Kostov, Michael Tolosa, William Chandler, Douglas J. Koebler, Joseph G. Cremonese, Brookman P. March
  • Patent number: 9883823
    Abstract: Systems and methods for determining an in vivo concentration of a small molecule substance of interest is provided that takes advantage of the semi-permeable nature of skin, which allows small molecules to passively diffuse through the skin and onto the skin surface. The systems and methods of the present invention allow for the collection of these small molecules that have passively diffused through the skin without skin disruption or breaking of the skin. The systems and methods of the present invention are noninvasive, painless and safe even for delicate newborns, and are particularly suited for the determination of blood glucose in newborns and infants in a noninvasive manner.
    Type: Grant
    Filed: February 4, 2013
    Date of Patent: February 6, 2018
    Assignee: University of Maryland Baltimore County
    Inventors: Leah Tolosa, Xudong Ge, Yordan Kostov, Michael Tolosa, Govind Rao
  • Publication number: 20170226467
    Abstract: A bioprocessing system for protein manufacturing from human blood is provided that is compact, integrated and suited for on-demand production and delivery of therapeutic proteins to patients. The patient's own blood can be used as the source of cell extracts for the production of the therapeutic proteins.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 10, 2017
    Inventors: Govind Rao, Yordan Kostov, Leah Tolosa, Kevin Tran, Monohar Pilli, Michael Tolosa, Chandrashekar Gurramkonda
  • Publication number: 20140038276
    Abstract: We provide a miniature, disposable reactor vessel for bioprocessing. Embodiments include a sealed vessel surrounding a filter through which spent media may be preferentially removed relative to culture cells. Preferred embodiments include an impeller shaft that is contained within the vessel and passes through the filter assembly. The impeller shaft may be engaged magnetically with a drive shaft. Combinations of these reactor vessels and methods of their use are also described.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 6, 2014
    Inventors: Joseph G. Cremonese, Joseph E. Qualitz, Brookman P. March, Michael Tolosa
  • Publication number: 20130253295
    Abstract: Systems and methods for determining an in vivo concentration of a small molecule substance of interest is provided that takes advantage of the semi-permeable nature of skin, which allows small molecules to passively diffuse through the skin and onto the skin surface. The systems and methods of the present invention allow for the collection of these small molecules that have passively diffused through the skin without skin disruption or breaking of the skin. The systems and methods of the present invention are noninvasive, painless and safe even for delicate newborns, and are particularly suited for the determination of blood glucose in newborns and infants in a noninvasive manner.
    Type: Application
    Filed: February 4, 2013
    Publication date: September 26, 2013
    Inventors: Leah TOLOSA, Xudong GE, Yordan KOSTOV, Michael TOLOSA, Govind RAO